Literature DB >> 932525

Effect of aging on renin activity and aldosterone excretion.

M G Crane, J J Harris.   

Abstract

Twenty or more normal subjects (half of whom were males) in each decade of life from age 20 to 80 years were included in the study. Plasma renin activity (PRA) was measured with the subjects on a normal sodium diet and after sodium restriction and standing. Aldosterone and sodium excretion rate was measured on unrestricted sodium intake and on day 3 of sodium restriction. Plasma renin activity was quantitated by both bioassay and radioimmunoassay of angiotensin-I. Plasma renin activity under both test conditions declined with increasing age, especially those over 40. Values of those in the seventh decade averaged 60 per cent of the value of that of the younger age group. Response of renin activity to sodium restriction and standing was 73 per cent of that of the younger age group. Older females tended to be less responsive to sodium restriction and standing. Aldosterone excretion rate declined with increasing age so that by the seventh decade the values averaged 55 per cent of those in the second decade of life. Aldosterone excretion rate in response to sodium restriction also declined with increasing age, particularly above the fourth decade, so that the values on day 3 of sodium restriction in the older subjects averaged 33 per cent of that of the subjects in the second decade of life. Renin substrate did not decline with increasing age. The decline in renin activity and aldosterone values in the older subjects appeared to be due to factors other than sodium or potassium intake.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932525

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  32 in total

Review 1.  Primary aldosteronism: rare bird or common cause of secondary hypertension?

Authors:  M Stowasser
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

Review 3.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

4.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

Review 5.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

6.  Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity.

Authors:  Taiki Hayashi; Zhen Zhang; Ghaith Al-Eyd; Atsushi Sasaki; Masanori Yasuda; Masafumi Oyama; Celso E Gomez-Sanchez; Hirotaka Asakura; Tsugio Seki; Kuniaki Mukai; Koshiro Nishimoto
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-08       Impact factor: 4.292

7.  Failure of methyclothiazide to lower home blood pressure level in "essential" hypertensive and normotensive young men, despite significant plasma volume contraction.

Authors:  R D Gordon; R H Mortimer; N Saar
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

Review 8.  Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.

Authors:  J H Bauer
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 9.  The elderly patient. A special case for diuretic therapy.

Authors:  D E Hyams
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 10.  Physiological changes due to age. Implications for drug therapy of congestive heart failure.

Authors:  R J Cody
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.